Petros Pharmaceuticals to Present at the Benzinga Healthcare Small Cap Conference
Petros Pharmaceuticals (Nasdaq: PTPI) announces its participation in the virtual Benzinga Healthcare Small Cap Conference from September 29-30, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Petros Pharmaceuticals (Nasdaq: PTPI) announces its participation in the virtual Benzinga Healthcare Small Cap Conference from September 29-30, 2021. President and Chief Commercial Officer Fady Boctor will present on September 30 at 2:40 PM ET and will be available for one-on-one meetings throughout the event. The company is focused on becoming a leading men's health provider by developing innovative therapeutics for various issues, including erectile dysfunction and hormone health.
Details
News Market Reaction – PTPI
The recorded move for PTPI in the trading session of this news was +1.63%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Sept. 23, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today that President and Chief Commercial Officer Fady Boctor will present at the Benzinga Healthcare Small Cap Conference, which is being held virtually from September 29 - 30, 2021.
Mr. Boctor will deliver his corporate presentation on September 30 at 2:40 PM ET.
Mr. Boctor will also be available for one-on-one meetings throughout the conference.
Investors can register here: https://www.benzinga.com/events/small-cap/healthcare/
About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.
View original content:https://www.prnewswire.com/news-releases/petros-pharmaceuticals-to-present-at-the-benzinga-healthcare-small-cap-conference-301383394.html
SOURCE Petros Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.